Registry for patients receiving implantable cardioverter defibrillators
Implantable Cardioverter Defibrillator (ICD Registry)
This study is collecting information from hospitals about patients who receive implantable defibrillators to see how well these devices are helping people and to improve care for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1750 (estimated) |
| Sex | All |
| Sponsor | American College of Cardiology Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Trial ID | NCT01999140 on ClinicalTrials.gov |
What this trial studies
The ICD Registry™ is a nationwide program designed to enhance the quality of care for patients receiving implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices with defibrillator (CRT-Ds). It collects comprehensive data on patient characteristics, treatments, and outcomes from participating hospitals, which submit this information quarterly to the American College of Cardiology Foundation's National Cardiovascular Data Registry. The registry aims to confirm the appropriateness of ICD utilization in Medicare patients and provides hospitals with outcomes reports for quality improvement. Enrollment began in 2005 in response to a mandate from the Centers for Medicare and Medicaid Services.
Who should consider this trial
Good fit: Ideal candidates include all patients receiving an ICD or CRT-D for primary or secondary prevention, particularly those insured by Medicare.
Not a fit: Patients who do not receive an ICD or CRT-D or those not covered by Medicare may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved care and outcomes for patients receiving ICDs and CRT-Ds.
How similar studies have performed: Other national registries have shown success in improving patient outcomes and care quality, indicating a positive precedent for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
All U.S and International patients. Inclusion Criteria: * All patients who receive an ICD/CRT-D (initial or generator change) for primary or secondary prevention purposes. * All patients with an ICD/CRT-D undergoing a Lead Only procedure. * U.S. populations must submit all patients who receive an ICD/CRT-D (initial or generator change) for primary prevention purposes who are insured by Medicare. Exclusion Criteria: None
Where this trial is running
Washington D.C., District of Columbia
- American College of Cardiology/National Cardiovascular Data Registry (NCDR) — Washington D.C., District of Columbia, United States (Recruiting)
Study contacts
- Study coordinator: NCDR Product Support
- Email: ncdr@acc.org
- Phone: 1-800-257-4737
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.